Log in or Sign up for Free to view tailored content for your specialty!
Glaucoma News
VIDEO: Surgeon discusses wide variety of MIGS options
NEW YORK — In this Healio Video Perspective from OSN New York, Nathan M. Radcliffe, MD, provides an overview of the products and tools in the pipeline for minimally invasive glaucoma surgery.
Second non-implant MIGS shows efficacy if trabecular bypass stent does not control IOP
A second non-implant MIGS intervention, namely canaloplasty and trabeculotomy, allows patients to achieve good IOP control if a prior trabecular micro-bypass stent has failed to maintain IOP as desired.
Log in or Sign up for Free to view tailored content for your specialty!
Patients from underserved areas are more likely to have glaucoma-related blindness
Patients who present with undiagnosed glaucoma at the emergency room, and are therefore more at risk for glaucoma-related blindness, are more likely to originate from underserved rural areas.
SURGICAL VIDEO: Singh performs goniotomy with Sion bladeless device
CHICAGO — In this exclusive surgical video for Healio/OSN, I. Paul Singh, MD, demonstrates a goniotomy using the new Sion surgical instrument, a manually operated bladeless device from Sight Sciences.
ECP data show long-term IOP control with low-risk profile
Amid all the anecdotes and discussions around our numerous options for minimally invasive glaucoma surgery, hard data have the unique power to cut through the noise.
Q&A: Registry focuses on long-term iTrack, iTrack Advance canaloplasty data
With support from Nova Eye Medical, a group of surgeons has launched a registry that will capture real-world data on canaloplasty procedures performed with the iTrack and iTrack Advance devices.
Higher smoking intensity linked with reduced optic nerve vessel density in glaucoma
Smoking intensity was linked with decreased optic nerve vessel density in patients with glaucoma, according to a study in Journal of Glaucoma.
VIDEO: Study compares treatment outcomes with glaucoma stents
CHICAGO — In this Healio Video Perspective from the AAO meeting, Mitchell C. Shultz, MD, discusses a study that compared the iStent inject W and Hydrus microstent to treat glaucoma in patients who have and have not undergone canaloplasty.
NCX 470 noninferior to latanoprost in phase 3 glaucoma trial
Once-daily dosing of NCX 470 demonstrated noninferiority compared with latanoprost in lowering IOP in patients with open-angle glaucoma or ocular hypertension in the phase 3 Mont Blanc clinical trial.
VIDEO: MicroPulse transscleral laser therapy aims to increase outflow to reduce IOP
CHICAGO — In this Healio Video Perspective from the AAO meeting, Ye Elaine Wang, MD, discusses MicroPulse transscleral laser therapy from Iridex.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read